COGNIS and TELIGEN are built on entirely new platforms, including
device hardware, software and programming interface. Both devices offer a
redundant hardware system called SafetyCore(TM), which provides lifesaving
shock therapy and basic pacing functionality in the unlikely event of a
system error. The products employ digital signal processing and are
equipped with increased levels of digital memory, enabling more patient
data to be captured and used by clinicians.
Key features of the COGNIS CRT-D include:
-- SmartDelay(TM) -- quickly proposes programmable device settings, which
enables physicians to tailor individualized pacing therapy for their
-- Bi-V Trigger -- helps physicians manage heart failure patients with
frequent atrial arrhythmias.
-- Electronic Repositioning(TM) -- provides physicians with six
configurations for stimulating the left side of the heart even after
implant, which may help avoid an additional surgical procedure.
Key features of the TELIGEN ICD include:
-- Thinnest ICD device available in the world -- the small size and
physiologic shape are designed with patient comfort in mind.
-- Quick Convert(TM) -- provides the ability for patients to receive
pacing therapy for ventricular tachycardias.
-- Enhanced AV Search algorithm -- designed to minimize unnecessary right
ventricular pacing. This feature, now with an extendable AV delay out
to 400 milliseconds, provides physicians with additional flexibility to
tailor device programming for individual patient needs.
COGNIS and TELIGEN are designed to be used with the LATITUDE(R) Patient Management System. The Company intends to offer LATITUDE support for COGNIS and TELIGEN as soon as possible following FDA approval.
Boston Scientific is a worldwide develo
|SOURCE Boston Scientific Corporation|
Copyright©2008 PR Newswire.
All rights reserved